155 related articles for article (PubMed ID: 38246983)
1. Development and Validation of a Pathomics Model Using Machine Learning to Predict CXCL8 Expression and Prognosis in Head and Neck Cancer.
Wang W; Ruan S; Xie Y; Fang S; Yang J; Li X; Zhang Y
Clin Exp Otorhinolaryngol; 2024 Feb; 17(1):85-97. PubMed ID: 38246983
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of CDKN2A in head and neck squamous cell carcinoma via pathomics and machine learning.
Wang Y; Zhou C; Li T; Luo J
J Cell Mol Med; 2024 May; 28(9):e18394. PubMed ID: 38751024
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of TNFRSF4 expression and development of a pathomics model to predict expression in hepatocellular carcinoma.
Yan Z; Li X; Li Z; Liu S; Chang H
Heliyon; 2024 Jun; 10(11):e31882. PubMed ID: 38841483
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a CECT-based radiomics model for predicting IL1B expression and prognosis of head and neck squamous cell carcinoma.
Xie Y; Wang M; Xia H; Sun H; Yuan Y; Jia J; Chen L
Front Oncol; 2023; 13():1121485. PubMed ID: 36969073
[TBL] [Abstract][Full Text] [Related]
5. A radiomics model to predict γδ T-cell abundance and overall survival in head and neck squamous cell carcinoma.
Fan B; Fan B; Sun N; Zou H; Gu X
FASEB J; 2024 Mar; 38(5):e23529. PubMed ID: 38441524
[TBL] [Abstract][Full Text] [Related]
6. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X
J Imaging Inform Med; 2024 Feb; ():. PubMed ID: 38376584
[TBL] [Abstract][Full Text] [Related]
7. Development of a Pathomics-Based Model for the Prediction of Malignant Transformation in Oral Leukoplakia.
Cai X; Li L; Yu F; Guo R; Zhou X; Zhang F; Zhang H; Zhang J; Li T
Lab Invest; 2023 Aug; 103(8):100173. PubMed ID: 37164265
[TBL] [Abstract][Full Text] [Related]
8. A Novel Model Based on CXCL8-Derived Radiomics for Prognosis Prediction in Colorectal Cancer.
Chu Y; Li J; Zeng Z; Huang B; Zhao J; Liu Q; Wu H; Fu J; Zhang Y; Zhang Y; Cai J; Zeng F
Front Oncol; 2020; 10():575422. PubMed ID: 33178604
[No Abstract] [Full Text] [Related]
9. Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.
Duan L; He Y; Guo W; Du Y; Yin S; Yang S; Dong G; Li W; Chen F
J Neurooncol; 2024 Jun; 168(2):283-298. PubMed ID: 38557926
[TBL] [Abstract][Full Text] [Related]
10. Effects of immune inflammation in head and neck squamous cell carcinoma: Tumor microenvironment, drug resistance, and clinical outcomes.
Zhu L; Wang Y; Yuan X; Ma Y; Zhang T; Zhou F; Yu G
Front Genet; 2022; 13():1085700. PubMed ID: 36579330
[No Abstract] [Full Text] [Related]
11. A comprehensive radiopathological nomogram for the prediction of pathological staging in gastric cancer using CT-derived and WSI-based features.
Tan Y; Feng LJ; Huang YH; Xue JW; Long LL; Feng ZB
Transl Oncol; 2024 Feb; 40():101864. PubMed ID: 38141376
[TBL] [Abstract][Full Text] [Related]
12. Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma.
Yang F; Zhou LQ; Yang HW; Wang YJ
Front Genet; 2022; 13():927614. PubMed ID: 36092911
[No Abstract] [Full Text] [Related]
13. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive radiomic analysis of enhanced CT predicts CTLA4 expression and prognosis in head and neck squamous cell carcinoma.
Zhu Y; Wu M
Sci Rep; 2023 Oct; 13(1):16782. PubMed ID: 37798374
[TBL] [Abstract][Full Text] [Related]
15. Development of a novel combined nomogram model integrating deep learning-pathomics, radiomics and immunoscore to predict postoperative outcome of colorectal cancer lung metastasis patients.
Wang R; Dai W; Gong J; Huang M; Hu T; Li H; Lin K; Tan C; Hu H; Tong T; Cai G
J Hematol Oncol; 2022 Jan; 15(1):11. PubMed ID: 35073937
[TBL] [Abstract][Full Text] [Related]
16. Exploring and validating the prognostic value of pathomics signatures and genomics in patients with cutaneous melanoma based on bioinformatics and deep learning.
Li X; Yu X; Tian D; Liu Y; Li D
Med Phys; 2023 Nov; 50(11):7049-7059. PubMed ID: 37722701
[TBL] [Abstract][Full Text] [Related]
17. Selecting Candidates for Organ-Preserving Strategies After Neoadjuvant Chemoradiotherapy for Rectal Cancer: Development and Validation of a Model Integrating MRI Radiomics and Pathomics.
Wan L; Sun Z; Peng W; Wang S; Li J; Zhao Q; Wang S; Ouyang H; Zhao X; Zou S; Zhang H
J Magn Reson Imaging; 2022 Oct; 56(4):1130-1142. PubMed ID: 35142001
[TBL] [Abstract][Full Text] [Related]
18. Association of the pathomics-collagen signature with lymph node metastasis in colorectal cancer: a retrospective multicenter study.
Jiang W; Wang H; Dong X; Zhao Y; Long C; Chen D; Yan B; Cheng J; Lin Z; Zhuo S; Wang H; Yan J
J Transl Med; 2024 Jan; 22(1):103. PubMed ID: 38273371
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of artificial intelligence pathomics models for predicting pathological staging in colorectal cancer: Using multimodal data and clinical variables.
Tan Y; Liu R; Xue JW; Feng Z
Cancer Med; 2024 Apr; 13(7):e6947. PubMed ID: 38545828
[TBL] [Abstract][Full Text] [Related]
20. A model of seven immune checkpoint-related genes predicting overall survival for head and neck squamous cell carcinoma.
Song D; Tian J; Han X; Li X
Eur Arch Otorhinolaryngol; 2021 Sep; 278(9):3467-3477. PubMed ID: 33449165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
